Center-Authored Papers

Filters: Keyword is Antimetabolites, Antineoplastic  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
T
Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, Ellenbogen RG, Olson JM, Zhang M.  2008.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.. Nanomedicine (London, England). 3(4):495-505. Abstract
Sekeres MA, Elson P, Kalaycio ME, Advani AS, Copelan EA, Faderl S, Kantarjian HM, Estey EH.  2009.  Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.. Blood. 113(1):28-36. Abstract
P
Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K et al..  2011.  PharmGKB summary: methotrexate pathway.. Pharmacogenetics and genomics. 21(10):679-86.
M
Bielas JH, Schmitt MW, Icreverzi A, Ericson NG, Loeb LA.  2009.  Molecularly evolved thymidylate synthase inhibits 5-fluorodeoxyuridine toxicity in human hematopoietic cells.. Human gene therapy. 20(12):1703-7. Abstract
E
Estey EH.  2013.  Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.. Leukemia. 27(9):1803-12. Abstract
D
Simon JA, Szankasi P, Nguyen DK, Ludlow C, Dunstan HM, Roberts CJ, Jensen EL, Hartwell LH, Friend SH.  2000.  Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.. Cancer research. 60(2):328-33. Abstract
C
Bhatla D, Gerbing RB, Alonzo TA, Conner H, Ross JA, Meshinchi S, Zhai X, Zamzow T, Mehta PA, Geiger H et al..  2009.  Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.. British journal of haematology. 144(3):388-94. Abstract
Medeiros BC, Othus M, Appelbaum FR.  2011.  Cytarabine dose for acute myeloid leukemia.. The New England journal of medicine. 364(22):2167-8;authorreply2168-9.
B
Fuchita M, Ardiani A, Zhao L, Serve K, Stoddard BL, Black ME.  2009.  Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.. Cancer research. 69(11):4791-9. Abstract
A
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP et al..  2009.  Adjuvant chemotherapy in older women with early-stage breast cancer.. The New England journal of medicine. 360(20):2055-65. Abstract